COVID-19 and its known variants, researchers around the world are in a race to find a universal vaccine that could protect against the current strain of the coronavirus as well as future ones.The U.S.
Army started Phase 1 clinical trials this week of a vaccine called Spike Ferritin Nanoparticle (SpFN) at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Md.
Over a dozen U.S. states to open up vaccines to all adults amid new COVID-19 surge Doctors at the Emerging Infectious Diseases Branch (EIDB) at WRAIR say the multi-faced sphere design of the vaccine is different from other vaccines already in use but they believe it could help provide broader protection against future strains of coronavirus.“It’s not just one spike.